Hans-Peter Deigner

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

International journal of molecular sciences

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Diagnostics (Basel, Switzerland)

Molecules (Basel, Switzerland)

Hochschule Furtwangen Fakultät Medical and Life Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hochschule Furtwangen Fakultät Medical and Life Sciences

Germany

Professor Molecular Pharmacology, Dean (2014-)

Hochschule Furtwangen Fakultät Medical and Life Sciences

Germany

Professor Molecular Pharmacology, Dean (2014-)

University of East Anglia

United Kingdom

Professor Biomedicinal Chemistry :: Pharmacy

Publications

Oliver Riester, Lars Kaiser, Stefan Laufer, Hans-Peter Deigner
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Markus Blaess, Rene Csuk, Teresa Schätzl, Hans-Peter Deigner
Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. International journal of molecular sciences 25 (17) (2024)
Oliver Riester, Lars Kaiser, Stefan Laufer, Hans-Peter Deigner
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Oliver Riester, Lars Kaiser, Stefan Laufer, Hans-Peter Deigner
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Oliver Riester, Lars Kaiser, Stefan Laufer, Hans-Peter Deigner
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Bassam Abu Thaher, Ihab Al-Masri, Kanan Wahedy, Rami Morjan, Saeb Aliwaini, Iman Mahmoud Al Atter, Aayat Ahmed Elmabhouh, Areej Khaled Al Ibwaini, Saba Luay Alkhaldi, Basem Qeshta, Claus Jacob, Hans-Peter Deigner
Synthesis and bioassay of 3-Aryl -1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]- triazin-4(3H)-ones as anti-cancer agents. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Simone Rentschler, Max Borgolte, Alexander Filbert, Stefan Laufer, Hans-Peter Deigner
Highly efficient β-lactamase assay applying poly-dimethylacrylamide-based surface functionalization with β-lactam antibiotics and β-lactamase inhibitors. Lab on a chip (2023)
Max Borgolte, Isabel Quint, Lars Kaiser, Rene Csuk, Hans-Peter Deigner
A Fluorescence-Based Competitive Antibody Binding Assay for Kynurenine, a Potential Biomarker of Kidney Transplant Failure. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Weronika Schary, Filip Paskali, Simone Rentschler, Christoph Ruppert, Gabriel E Wagner, Ivo Steinmetz, Hans-Peter Deigner, Matthias Kohl
Open-Source, Adaptable, All-in-One Smartphone-Based System for Quantitative Analysis of Point-of-Care Diagnostics. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Simone Rentschler, Lars Kaiser, Hans-Peter Deigner
Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance. International journal of molecular sciences 22 (1) (2021)
Max Borgolte, Oliver Riester, Tereza Kacerova, Simone Rentschler, Magnus S Schmidt, Susanne Jacksch, Markus Egert, Stefan A Laufer, Rene Csuk, Hans-Peter Deigner
Methacryloyl-GlcNAc Derivatives Copolymerized with Dimethacrylamide as a Novel Antibacterial and Biocompatible Coating. Pharmaceutics 13 (10) (2021)
Lars Kaiser, Isabel Quint, Rene Csuk, Manfred Jung, Hans-Peter Deigner
Lineage-Selective Disturbance of Early Human Hematopoietic Progenitor Cell Differentiation by the Commonly Used Plasticizer Di-2-ethylhexyl Phthalate via Reactive Oxygen Species: Fatty Acid Oxidation Makes the Difference. Cells 10 (10) (2021)
Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Rene Csuk, Hans-Peter Deigner
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International journal of molecular sciences 22 (4) (2021)
Teresa Schätzl, Lars Kaiser, Hans-Peter Deigner
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update. Orphanet journal of rare diseases 16 (1) (2021)
Abid Ali Khan, Khanzadi Nazneen Manzoor, Aamir Sultan, Maria Saeed, Mahrukh Rafique, Sameen Noushad, Ayesha Talib, Simone Rentschler, Hans-Peter Deigner
Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria. International journal of molecular sciences 22 (2) (2021)
Saeb Aliwaini, Bassam Abu Thaher, Ihab Al-Masri, Nabil Shurrab, Said El-Kurdi, Dieter Schollmeyer, Basem Qeshta, Mariam Ghunaim, Rene Csuk, Stefan A Laufer, Lars Kaiser, Hans-Peter Deigner
Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents. Molecules (Basel, Switzerland) 26 (13) (2021)
Christoph Ruppert, Lars Kaiser, Lisa Johanna Jacob, Stefan Laufer, Matthias Kohl, Hans-Peter Deigner
Duplex Shiny app quantification of the sepsis biomarkers C-reactive protein and interleukin-6 in a fast quantum dot labeled lateral flow assay. Journal of nanobiotechnology 18 (1) (2020)
Lars Kaiser, Helga Weinschrott, Isabel Quint, Markus Blaess, Rene Csuk, Manfred Jung, Matthias Kohl, Hans-Peter Deigner
Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic Pathways. International journal of molecular sciences 21 (17) (2020)
Sophie Hoenke, Immo Serbian, Hans-Peter Deigner, Rene Csuk
Mitocanic Di- and Triterpenoid Rhodamine B Conjugates. Molecules (Basel, Switzerland) 25 (22) (2020)
Nico Laur, Ralf Kinscherf, Karolina Pomytkin, Lars Kaiser, Otto Knes, Hans-Peter Deigner
ICP-MS trace element analysis in serum and whole blood. PloS one 15 (5) (2020)

Hans-Peter Deigner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hans-Peter Deigner